Osteoarthritis, Knee study: Low dose radiotherapy
Official title Radio- KO Radiotherapy for Knee Osteoarthritis Clinical Trial
ClinicalTrials.gov ID: NCT06887829
What this study is testing
- What it's testing
- This study is testing whether low‑dose radiotherapy can reduce knee pain. It also looks at whether it causes more side effects than a pretend treatment.
- Who it's for
- You may be able to join if you have knee osteoarthritis and are looking for new ways to manage pain.
- What's involved
- You will receive a small amount of radiation to your knee. You will also get a pretend treatment to compare. You will have visits to check your pain and any side effects.
- Time commitment
- The study lasts a few weeks, with several visits to receive treatments and report your pain and side effects.
- Time commitment: about 6 months
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 100
You may be able to join if
- Age 50-100 years with a Mayo Clinic Rochester primary care provider At least moderate constant (ICOAP item A1) or intermittent (ICOAP item B6) pain...
You likely can't join if
- Pregnancy or childbearing potential without surgical sterilization Recent knee trauma is causing the current pain History of inflammatory arthritis...
The study team makes the final eligibility decision.
Where it is enrolling
- Rochester, Minnesota, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The study runs about 6 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Rochester, Minnesota, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.